FDA
approval
· 2025-08-01
FDA Approved: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Alembic Pharmaceuticals Inc.)
Summary
The FDA approved Alembic Pharmaceuticals' supplemental application for a generic fixed-dose combination tablet of olmesartan medoxomil and hydrochlorothiazide.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE (OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE)